A spiky, pollen shaped particle kills wound bacteria with reactive oxygen species and drips antigens into the tissue, training the immune system to stop reinfection.
Recurrent wound infections persist not because the bacteria are unbeatable, but because the wound rarely receives a slow, sustained signal that trains local immunity to recognize them. Pollen delivers that signal to the nose every spring. A 2026 Advanced Materials paper borrows the playbook.
The result is VAE-Pollen, a designed, spiky pollen-shaped particle built around a vanadium artificial enzyme. Its micro-structured surface physically snags bacteria. Engineered oxygen vacancies on the vanadium broaden the particle's reactive oxygen species (ROS) catalysis, killing the captured cells. As the bacteria die, the particle releases their antigens in a slow drip that mimics natural pollen exposure and primes local immune defenses.
In mouse wound models infected with methicillin-resistant Staphylococcus aureus (MRSA), the authors report the particle cleared the infection and prevented reinfection.
The work is preclinical. A single paper, no human safety data, and the immune-priming effect is shown in controlled experimental infections rather than in immunologically diverse populations. Toxicology, dosing, and head-to-head comparisons against standard antibiotic care remain open.